'The days when health officials could issue advice, based on the very best medical and scientific data, and expect populations to comply, may be fading.' Margaret Chan, WHO Director-General, Report to the 126th Executive Board, 2010.
Age of Autism publishes the abstract of the recent paper by Oller et al reviewing the evidence that the WHO spiked tetanus vaccines in Kenya with a birth control drug it developed, HCG. Predictably the controversy was laid at the door of "anti-vaxxers" but it is apparent that this has nothing to do with original context: the Catholic church is not "anti-vaccine" and it seems highly implausible that the testing laboratory signed its own death warrant by detecting something which was not there. The problem would seem to lie with the untrustworthy behavior of the World Health Organization, its not so hidden agendas, the Gates Foundation and the Kenyan government.
HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World
John W. Oller, Christopher A Shaw, Lucija Tomljenovic, Stephen K. Karanja, Wahome Ngare, Felicia M. Clement, Jamie Ryan Pillette
In 1993, WHO announced a “birth-control vaccine” for “family planning”. Published research shows that by 1976 WHO researchers had conjugated tetanus toxoid (TT) with human chorionic gonadotropin (hCG) producing a “birth-control” vaccine. Conjugating TT with hCG causes pregnancy hormones to be attacked by the immune system. Expected results are abortions in females already pregnant and/or infertility in recipients not yet impregnated. Repeated inoculations prolong infertility. Currently WHO researchers are working on more potent anti-fertility vaccines using recombinant DNA. WHO publications show a long-range purpose to reduce population growth in unstable “less developed countries”. By November 1993 Catholic publications appeared saying an abortifacient vaccine was being used as a tetanus prophylactic. In November 2014, the Catholic Church asserted that such a program was underway in Kenya. Three independent Nairobi accredited biochemistry laboratories tested samples from vials of the WHO tetanus vaccine being used in March 2014 and found hCG where none should be present. In October 2014, 6 additional vials were obtained by Catholic doctors and were tested in 6 accredited laboratories. Again, hCG was found in half the samples. Subsequently, Nairobi’s AgriQ Quest laboratory, in two sets of analyses, again found hCG in the same vaccine vials that tested positive earlier but found no hCG in 52 samples alleged by the WHO to be vials of the vaccine used in the Kenya campaign 40 with the same identifying batch numbers as the vials that tested positive for hCG. Given that hCG was found in at least half the WHO vaccine samples known by the doctors involved in administering the vaccines to have been used in Kenya, our opinion is that the Kenya “anti-tetanus” campaign was reasonably called into question by the Kenya Catholic Doctors Association as a front for population growth reduction.